U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900140) titled 'Adjunctive Methylene Blue in Septic Shock' on March 20.
Brief Summary: Adjunctive Methylene BLUe in Septic SHock (BLUSH) is a single centre concealed-allocation parallel-group open-label randomized controlled pilot trial to ascertain the feasibility of a trial evaluating the efficacy and safety of adjunctive methylene blue infusion compared to usual care on outcomes of adult patients admitted to the intensive care unit with septic shock.
Study Start Date: March 24
Study Type: INTERVENTIONAL
Condition:
Septic Shock
Intervention:
DRUG: Methylene Blue
Continuous methylene blue infusion at a fixed dose of 0.50 mg/kg/hour (dilute...